ELITE PHARMACEUTICALS INC /NV/ Quarterly Current Ratio in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Current Ratio history and growth rate from Q4 2011 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Current Ratio for the quarter ending September 30, 2024 was 280 %, a 9.51% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 280 +24.4 +9.51% Sep 30, 2024
Q2 2024 237 -99.6 -29.5% Jun 30, 2024
Q1 2024 220 -192 -46.6% Mar 31, 2024
Q4 2023 208 -212 -50.4% Dec 31, 2023
Q3 2023 256 -116 -31.3% Sep 30, 2023
Q2 2023 337 +13.1 +4.03% Jun 30, 2023
Q1 2023 412 +149 +56.6% Mar 31, 2023
Q4 2022 419 +174 +70.8% Dec 31, 2022
Q3 2022 372 +151 +68.1% Sep 30, 2022
Q2 2022 324 +118 +57.3% Jun 30, 2022
Q1 2022 263 +77.5 +41.8% Mar 31, 2022
Q4 2021 246 +82.8 +50.9% Dec 31, 2021
Q3 2021 222 +78.5 +54.9% Sep 30, 2021
Q2 2021 206 +79.7 +63.1% Jun 30, 2021
Q1 2021 186 +70.2 +60.9% Mar 31, 2021
Q4 2020 163 +45.4 +38.7% Dec 31, 2020
Q3 2020 143 +21 +17.2% Sep 30, 2020
Q2 2020 126 -12.4 -8.91% Jun 30, 2020
Q1 2020 115 -52.7 -31.4% Mar 31, 2020
Q4 2019 117 -86.2 -42.3% Dec 31, 2019
Q3 2019 122 -131 -51.7% Sep 30, 2019
Q2 2019 139 -161 -53.8% Jun 30, 2019
Q1 2019 168 -182 -52% Mar 31, 2019
Q4 2018 204 -218 -51.7% Dec 31, 2018
Q3 2018 253 -209 -45.2% Sep 30, 2018
Q2 2018 300 -151 -33.4% Jun 30, 2018
Q1 2018 350 -87.6 -20% Mar 31, 2018
Q4 2017 421 +23 +5.78% Dec 31, 2017
Q3 2017 461 +119 +34.8% Sep 30, 2017
Q2 2017 451 +143 +46.4% Jun 30, 2017
Q1 2017 437 +140 +47.3% Mar 31, 2017
Q4 2016 398 +129 +48% Dec 31, 2016
Q3 2016 342 +55.1 +19.2% Sep 30, 2016
Q2 2016 308 +6.46 +2.14% Jun 30, 2016
Q1 2016 297 +56.9 +23.7% Mar 31, 2016
Q4 2015 269 +52.2 +24.1% Dec 31, 2015
Q3 2015 287 +161 +127% Sep 30, 2015
Q2 2015 301 +224 +289% Jun 30, 2015
Q1 2015 240 +187 +353% Mar 31, 2015
Q4 2014 217 +184 +556% Dec 31, 2014
Q3 2014 126 +93.1 +279% Sep 30, 2014
Q2 2014 77.5 +42.2 +120% Jun 30, 2014
Q1 2014 53 +18.6 +54% Mar 31, 2014
Q4 2013 33 +2.58 +8.48% Dec 31, 2013
Q3 2013 33.3 +2.32 +7.49% Sep 30, 2013
Q2 2013 35.2 -0.09 -0.26% Jun 30, 2013
Q1 2013 34.4 -8.02 -18.9% Mar 31, 2013
Q4 2012 30.4 -20.6 -40.4% Dec 31, 2012
Q3 2012 31 Sep 30, 2012
Q2 2012 35.3 Jun 30, 2012
Q1 2012 42.4 Mar 31, 2012
Q4 2011 51.1 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.